A new study published in the Journal of Clinical Endocrinology & Metabolism reveals that anti-Müllerian hormone (AMH) levels can predict a woman's reproductive age and onset of menopause. AMH levels reflect the number of small follicles present in a woman's ovaries, enabling monthly ovulations.
Researchers found that administration of triflusal increased insulin secretion significantly in relation to dose size, but did not improve insulin sensitivity. The study's findings suggest salicylates may have a therapeutic benefit in the fight against type 2 diabetes in obese individuals.
A 12-month study found that testosterone patches improved bone density, body composition, and cognitive function in women with low testosterone levels resulting from hypopituitarism. The patches showed few side effects, making them a potential treatment option for these women.
A new study found that combining bright light and melatonin can help advance the circadian clock and reduce jet lag. The combination produces a larger phase advance than bright light alone, making it a practical solution for travelers.
Infants of mothers with posttraumatic stress syndrome disorder (PTSD) symptoms after 9/11 have significantly lower cortisol levels compared to those born to mothers without the condition. This effect is observed both in utero and after birth, suggesting a potential biological risk factor for PTSD.
A study by Julie Mennella and colleagues found that moderate alcohol consumption decreases oxytocin levels, which affects milk ejection and production. The increased prolactin levels associated with breast fullness may also contribute to the decline of milk production.
Study reveals nearly two times higher likelihood of metabolic syndrome in women with PCOS, leading to increased risk of early-onset cardiovascular disease. Women with both conditions exhibit more severe insulin resistance.
A one-year study found growth hormone treatment significantly reduced intra-abdominal fat and improved insulin sensitivity in postmenopausal women with abdominal adiposity. The treatment also increased thigh muscle area and lowered LDL cholesterol concentration.
The Endocrine Society recommends classifying childhood obesity as a legitimate disease to encourage public funding and insurer reimbursement for treatment programs. This classification aims to prevent and treat obesity in children, reducing serious health risks such as diabetes, heart disease, and respiratory disorders.
Researchers found that lean mass, intra-abdominal fat, and inflammation biomarker sTNFR1 are higher in women with metabolic syndrome, independently related to its severity. Analysis of these factors can help doctors identify postmenopausal women at increased risk for diabetes and heart disease.
Research finds that rosiglitazone effectively treats PCOS symptoms, while valproate increases incidence of PCOS in women. Carotid artery thickness is also linked to increased risk for heart disease in women with PCOS. Furthermore, sleep apnea may increase risk for diabetes in women with PCOS.
Low thyroid hormone levels affect an estimated 40,000 pregnant and 1.6 million nonpregnant women in the US, with 3.1% of reproductive age women having low levels. Targeted screening before pregnancy may prevent developmental issues.
Recent studies have highlighted promising new treatments for obesity, including rimonabant's effectiveness in treating the condition. Additionally, researchers have discovered a lack of gut hormone PYY3-6 in obese individuals, leading to increased food intake and potential health risks associated with obesity.
Researchers found that high school students, both athletes and non-athletes, use anabolic steroids and body-shaping drugs regularly. Students with a higher grade-point average tend to use less drugs, while those with lower GPAs are more likely to use these substances.
Two studies show that women with PCOS are at higher risk for cardiovascular disease due to elevated CRP levels and metabolic abnormalities. Obese women with PCOS symptoms are particularly at risk, highlighting the need for close monitoring of CVD risk factors in this population.
Researchers found that elderly women with low vitamin B-12 levels experience rapid hip bone loss, a risk factor for fractures. Simple dietary supplements or multivitamins may help slow bone loss rates.
Researchers found that achieving basal growth hormone levels of less than 2.5 µg/liter and glucose-suppressed GH levels of less than one µg/liter may not minimize cardiovascular risks in acromegaly patients. Instead, these patients are at increased risk for conditions like hypertension, diabetes, and osteoarthritis.
Recent studies show that overweight Hispanic youth are at an increased risk for developing type 2 diabetes and cardiovascular disease. Insulin resistance directly contributes to the development of metabolic syndrome, particularly in those with a family history of diabetes.
A new study finds evidence of genetic linkages to metabolic syndrome in both black and white patients. The researchers also identified chromosomal regions linked to cardiovascular disease and type 2 diabetes risk factors. These findings bring us closer to discovering the actual genes responsible for metabolic syndrome.
Researchers propose combining SERMs with estrogen to prevent breast cancer and improve menopausal symptoms, such as hot flashes and cognitive function. The study found that EM-652 blocks estrogen's negative effects while protecting bone and decreasing serum lipids.